Therefore, this study investigated the role and binding mechanism of quinoa derived bioactive peptides for inhibiting enzymatic markers i.e., CEase and PL that are responsible for hypercholesterolemia. This evidence concerns the gene PNLIP and Hypercholesterolemia.